Factors associated with severe skin disorder after extravasation of intravenously infused antineoplastic agents, Yuko.Matsui,, Ryoko.Murayama, Hidenori.Tanabe, Makoto.Oe, Yoshiharu.Motoo, Takanori.Wagatsuma, Michiko.Michibuchi, Sachiko.Kinoshita, Keiko.Sakai, Chizuko.Konya, Junko.Sugama, Hiromi.Sanada, Journal of Nursing Science and Engineering, 5:31-40, 2018
Ramucirumab plus paclitaxel: a possible new chemotherapy regimen for neuroendocrine carcinoma of the stomach, Motoo Y, Internal Medicine, 57:631-632, Mar. 2018
In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs, (Kita.Kenji), Arai.Sachiko, Nishiyama. Akihiro, Taniguchi. Hirokazu, Fukuda.Koji, Wang.Rong,Yamada.Tadaaki,Takeuchi.Shinji, Tange. Shoichiro,Tajima. Atsushi, Nakada. Mitsutoshi,Yasumoto. Kazuo, Motoo.Yoshiharu, Murakami.Takashi, Yano.Seiji, Cancer Medicine, 6:2972-2983, Dec. 2017
Evaluation of the predictive validity of thermography in identifying extravasation with intravenous chemotherapy infusions, Yuko.Matsui, Ryoko.Murayama, Hidenori.Tanabe, Makoto.Oe, Yoshiharu.Motoo, Takanori.Wagatsuma, Michiko.Michibuchi, Sachiko.Kinosita, Keiko.Sakai, Chizuko.Konya, Junko.Sugama, Hiromi.Sanada, Journal of Infusion Nursing, 40:367-374, Nov. 2017
Long-term survival due to combination therapy in a patient with locally advanced body-tall pancreatic cancer, Nobuhiko.Ueda, Yoritaka.Fujii, Seiko.Miura, Jun. Fujita, Yasuto.Tomita, Toshio.Ohnishi, Hideto.Fujita, Shinichi.Kinami, Kazuhiko.Omote, Yasuharu.Nakano, Takeo.Kosaka, Yoshiharu.Motoo, Japanese Journal of Cancer and Chemotherapy, 44:1373-1375, Nov. 2017
Effect of ninjin'yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice, (Suzuki.Toshiaki), Yamamoto. Ayano, Ohsawa.Masahiro, Motoo. Yoshiharu, Mizukami. Hajime, Makino.Toshiaki, Journal of Natural Medicines, 71:757-764, Oct. 2017
Standards of reporting Kampo products (STORK) in research articles, Y Motoo,T Hakamatsuka,N Kawahara,I AraiI,K Tsutani., Journal of Integrative Medicine, 15:182-185, Apr. 2017
Economic burden and mental distress in using complementary and alternative medicine, and formal supports by medical professional of japanese patients with chronic diseases, Keiko.Yukawa, Hirono.Ishikawa, Yoshihiko.Yamazaki, Jimpei.Misawa, Kiichiro.Tsutani, Ichiro.Arai, Yoshiharu.Motoo, Takahiro.Kiuchi, Japanese Pharmacology & Therapeutics, 45:345-355, Feb. 2017
Clinical study on the efficacy and continuous docetaxel based chemotherapy treatment for castration-resistant prostate cancer, Ippei.Chikazawa, Shinya.Inoue, Yusuke.Nakazawa, Dan.Nakai, Nobuyo.Morita, Tatsuro.Tanaka, Yoshiharu.Motoo and Katsuhito.Miyazawa, 63:351-357, 2017
Identification and functional analysis of an EMT-accelerating factor induced in pancreatic cancer cells by an anticancer agent, T.Shimasaki, S.Yamamoto, Y.Ishigaki, T.Takata, T.Arisawa, Y.Motoo, N.Tomosugi, T.Minamoto, Suizo, 31:76-84, 2016
Description of Kampo medicines in the clinical practice guidelines for irritable bowel syndrome, Y.Motoo, Journal of Gastroenterology, 50:816-816, Jul. 2015
Ninjin'yoeito and ginseng extract prevent oxaliplatin-induced neurodegeneration in PC12 cells, (T.Suzuki), A.Yamamoto, M.Ohsawa, Y.Motoo, H.Mizukami, T.Makino, Journal of Natural Medicines, 69:531-537, 2015
Survey on health hazards indirectly caused by complementary and alternative medicine in Japan, (K.Tsutani), K.Yukawa, M.Nagasawa, I.Arai, A.Igarashi, H.Ogasawara, K.Tsuruoka, S.Fukuyama, Y.Motoo, Y.Yamazaki, 42:1005-1014, Dec. 2014
Effect of saikokeishito, a kampo medicine, on hydrogen peroxide-induced premature senescence of normal human dermal fibroblasts, T. Takata, Y. Motoo, N. Tomosugi, Journal of integrative medicine., 12:495-503, Nov. 2014
Treatment with kampo medicines fo reflex sympathetic dystrophy, post-optic nerve meningioma operation and traffic injury, J.Moriya, J.Yamakawa, K.Takeuchi, Y.Motoo, J.Kobayashi, 24:144-148, May. 2014
Analysis of thermographic images in an extravasation model of intravenous infusion in healthy adults, Y.Matsui, R.Murayama, H.Tanabe, M.Oe, M.Fukuda, Y.Motoo, T.Wagatsuma, S.Kinoshita, K.Sakai, C.Konya, J.Sugama, H.Sanada, 1:4-11, Apr. 2014
Successful treatment of post-influenza chronic fatigue syndrome with kampo medicine:a case report, J.Moriya, K.Takeuchi, H.Uenishi, S.Akazawa, Y.Motoo, H.Hashimoto, M.Kaneshima, J.Kobayashi, J.Yamakawa, 65:87-93, Feb. 2014
Whole Person Care, 60:93-94, Jan. 2014
Use of Kampo diagnosis in randomized controlled trials of Kampo products in Japan: a systematic review, Y.Motoo, I.Arai, K,Tsutani, PloS one, 9:e104422;1-9, 2014
Acupuncture and herbal medicine for cancer patients 2014, (T.Efferth), S.Lee, Y.Motoo, S.Schroder, Evidence-based complementary and alternative medicine : eCAM., 2014,326179;1-2, 2014
A case of leg pain associated with lumber spinal canal stenosis in patient with Parkinson disease treated by yokukansan., J.Moriya, J.Yamakawa, K.Takeuchi, Y.Motoo, 23:114-117, May. 2013
Significance of kampo, japanese traditional medicine, in the treatment of obesity:basic and clinical evidence., J.Yamakawa, J.Moriya, K.Takeuchi, M.Sawada, Y.Motoo, J.Kobayashi, Evidence-based complementary and alternative medicine : eCAM., 2013,943075;1-8, Mar. 2013
Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients., J.Yamakawa, Y.Motoo, J.Moriya, M.Ogawa, H.Uenishi, S.Akazawa, T.Sasagawa, M.Nishio, J.Kobayashi, Evidence-based complementary and alternative medicine : eCAM., 2013,746486;1-10, Mar. 2013
Role of Kampo medicine in integrative cancer therapy., J.Yamakawa, Y.Motoo, J.Moriya, M.Ogawa, H.Uenishi, S.Akazawa, T.Sasagawa, M.Nishio, J.Kobayashi, Evidence-based complementary and alternative medicine : eCAM., 2013:570848;1-6, Mar. 2013
Neuroendcrine carcinoma of the prostate treated combined modality therapy., I.Chikazawa, D.Nakai, K.Miyazawa, T.Tanaka, K.Suzuki, K.Sato, Y.Motoo, 59:99-104, Feb. 2013
Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy., (A.Kitano), T.Shimasaki, Y.Chikano, M.Nakada, M.Hirose, T.Higashi, Y.Ishigaki, Y.Endo, T.Takino, H.Sato, Y.Sai, K.Miyamoto, Y.Motoo, K.Kawakami, T.Minamoto, PloS one, 8:e55289;1-12, Feb. 2013
Meaning of tumor protein 53-induced nuclear protein 1 in the molecular mechanism of gemcitabine sensitivity., N.Nakaya, Y.Ishigaki, H.Nakajima, M.Murakami, T.Shimasaki, T.Takata, M.Ozaki, NJ.Dusetti, JL.Iovanna, Y.Motoo, Molecular and clinical oncology., 1:100-104, Jan. 2013
Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events, T.Fukushima, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sato, T.Sakai, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, H.Nakajima, Y.Motoo, H.Umehara, Anticancer research., 31:2297-2302, Sep. 2011
A Case of primary cardiac angiosarcoma associated with cardiac tamponade, N.Nakaya, I.Sato, T.Shimasaki, H.Nakajima, N.Kurose, T.Nojima, Y.Motoo, 38:1353-1355, Aug. 2011
Traditional Japanese medicine, Kampo: Its history and current status, Y.Motoo, T.Seki, K.Tsutani, Chinese journal of integrative medicine, 17:85-87, Feb. 2011
Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: Implications for new therapeutic strategies, Y.Motoo, T.Shimasaki, Y.Ishigaki, H.Nakajima, K.Kawakami, T.Minamoto, Cancers, 3:446-460, Jan. 2011
Human SMG-1 is involved in gemcitabine-induced primary microRNA-155/BIC up-regulation in human pancreatic cancer PANC-1 cells, (QS.Xia), Y.Ishigaki, X.Zhao, T.Shimasaki, H.Nakajima, H.Nakagawa, T.Takegami, ZH.Chen, Y.Motoo, Pancreas., 40:55-60, Jan. 2011
Combination chemotherapy of docetaxel and uft against hormone refractory prostate cancer, T.Shimasaki, K.Miyazawa, M.Moriyama, T.Tanaka, I.Sato, N.Nakaya, H.Nakajima, A.Kubo, K.Suzuki, Y.Motoo, 57:163-166, 2011
Scanning electron microscopy with an ionic liquid reveals the loss of mitotic protrusions of cells during the epithelial-mesenchymal transition, Y.Ishigaki, Y.Nakamura, T.Takehara, T.Shimasaki, T.Tatsuno, F.Takano, Y.Ueda, Y.Motoo, T.Takegami, H.Nakagawa, S.Kuwabata, N.Nemoto, N.Tomosugi, S.Miyazawa, Microscopy research and technique, 74:1024-1031, 2011
Epithelial- to- mesenchymal transition in pancreatic adenocarcinoma, (C.Cano), Y.Motoo, JL.Lovanna, The Scientific World Journal, 10:1947-1957, Oct. 2010
Curatively resected case of non-functioning pancreatic neuroendocrine carcinoma with multiple liver metasta-ses after dpwmstaging with S-1 monotherapy, I.Sato, N.Ueda, E.Kinoshita, H.Mnato, K.Ohno, N.Nakata, T.Shimasaki, H.Nakajima, T.Kosaka, Y.Motoo, 37:1341-1344, Jul. 2010
A case of carpal tunnel syndrome treated by the combination with san'oshashinto and tokakujokito, J.Moriya, J.Yamakawa, Y.Motoo, 20:81-83, Jun. 2010
Two cases of atypical adenoma of the thyroid―is atypical adenoma of the thyroid a true benign lesion?―, (M.Tachibana), Y.Hashimoto, T.Sone, N.Ooishi, T.Ueno, Y.Motoo, 49:190-195, Mar. 2010
Application of molecular medicine to pancreatic cancer, T.Shimasaki, Y.Ishigaki, T.Minamoto, Y.Motoo, 25:35-45, Jan. 2010
A Kampo medicine, boiogito, inhibits obesity in ovariectomized rats, J.Yamakawa, J.Moriya, T.Takahashi, A.Ishige, Y.Motoo, F.Yoshizaki, T.Kanda, Evidence-based complementary and alternative medicine : eCAM., 7:87-95, Jan. 2010
Molecular analysis on responses of TP53INP1-knockout mouse embryonic fibroblasts to anti-cancer agents, (Q.Bian), Y.Motoo, H.Nakajima, T.Shimasaki, Y.Ishigaki, 125-128, 2010
Induction of HITS, a newly identified family with sequence similarity 107 protein (FAM107B), in cancer cells by heat shock stimulation, H.Nakajima, Y.Ishigaki, QI-S.Xia, T.Ikeda, Y.Yoshitake, H.Yonekura, T.Nojima, T.Tanaka, H.Umehara, N.Tomosugi, T.Takata, T.Shimasaki, N.Nakaya, I.Sato, K.Kawakami, K.Koizumi, T.Minamoto, Y.Motoo, International journal of oncology, 37:583-593, 2010
The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells, (QM.Zhou), S.Wamg, H.Zhang, YY.Lu, XF.Wang, Y.Motoo, SB.Su, Acta pharmacologica Sinica, 30:1648-1658, Dec. 2009
An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3beta., (K.Miyashita), M.Nakada, K.Shakoori, Y.Ishigaki, T.Shimasaki, Y.Motoo, Kawakami K, T.Minamoto, Anti-cancer agents in medicinal chemistry, 9:1114-1122, Dec. 2009
Deregulated GSK3β Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase, (W.Mai), K.Kawakami, A.Shakoori, S.Kyo, K.Miyashita, K.Yokoi, M.Jin, T.Shimasaki, Y.Motoo, T.Minamoto, Clinical cancer research : an official journal of the American Association for Cancer Research., 15:6810-6819, Nov. 2009
Effect of kampo medicine on the long-termadministration of NSAIDs in three cases of gonarthrosis, J.Moriya, J.Yamakawa, Y.Motoo, 18:82-87, Jun. 2008
A case undergoing repeated anaphylactic shok after systemic administration of vinorelbine, Y.Takahashi, T.Kiba, K.Yamaguchi, Y.Saitou, K.Nishio, M.Iguchi, Y.Motoo, 34:2321-2323, Dec. 2007
A kampo medicine, boi-ogi-to, inhibits obesity in ovariectomized rats, J.Yamakawa, J.Moriya, T.Takahashi, A.Ishige, Y.Motoo, F.Yoshizaki, T.Kanda, eCAM, 42013, Nov. 2007
Large defects of type l allergic response in telomerase reverse transcriptase knockout mice, (A.Ujike-Asai), A.Okada, Y.Du, M.Maruyama, X.Yuan, F.Ishikawa, Y.Motoo, K.Isobe, H.Nakajima, Journal of leukocyte biology, 82:429-435, Aug. 2007
Expression of interleukin-22 in human melanoma cell line.(in Chinese), (J.Pei-hong), Y.Motoo, J. Clin. Dermatology., 36:346-347, Jun. 2007
Apoptosis-related gene expression profile is changed by gemcitabine in pancreatic cancer cell line(PANC-1), T.Shimasaki, Y.Ishigaki, T.Minato, Y.Motoo, 22:14-20, Mar. 2007
Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine., (D.Closa), Y.Motoo, JL.Iovanna, World journal of gastroenterology : WJG., 13:170-174, Feb. 2007
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development., (M.Gironella), M.Seux, M-J.Xie, C.Cano, R.Tomasini, J.Gommeaux, S.Garcia, J.Nowak, ML.Yeung, K-T.Jeang, A.Chaix, L.Fazli, Y.Motoo, Q.Wang, P.Rocchi, A.Russo, M.Gleave, J-C.Dagorn, JL.Iovanna, A.Carrier, M-J.Pebusque, NJ.Dusetti, Proceedings of the National Academy of Sciences of the United States of America, 104:16170-16175, 2007
Suppressive effect of herbal medicine saikokeishito on acinar cell apoptosis in rat spontaneous chronic pancreatitis, (S-B.Su), M-J.Xie, N.Sawabu, Y.Motoo, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 7:28-36, 2007
High level of tumour protein p53-induced nuclear protein 1 (TP53INP1) expression in anaplastic carcinoma of the thyroid, (Y.Ito), Y.Motoo, H.Yoshida, JL.Iovanna, Y.Nakamura, K.Kuma, A.Miyauchi, Pathology, 38:545-547, Dec. 2006
Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma., (Ito Y), Motoo Y, Yoshida H, Iovanna JL, Takamura Y, Miya A, Kuma K, Miyauchi A, Anticancer research., 26(6B):4391-4395., Nov. 2006
Effectiveness of goshajinkigan on the cold sensation and dysthesia in a case of nodular multiple angiitis, J.Yamakawa, J.Moriya, K.Kusaka, T.Itoh, Y.Motoo, T.Kanda, 57:651-654, Sep. 2006
Effects of Chinese herbal medicines on spontaneous chronic pancreatitis in rats and the pathological relationships between formulas and syndromes., Journal of Chinese Integrative Medicine, 4: 358-362, Jul. 2006
Effects of Chinese herbal medicines on spontaneous chronic pancreatitis in rats and the pathological relationships between formulas and syndromes., (Su SB), Li YQ, Shen HY, Motoo Y, Journal of Chinese Integrative Medicine, 4: 358-62, Jul. 2006
Effects of Chinese herbal medicines on spontaneous chronic pancreatitis in rats and the pathological relationships between formulas and syndromes, (SB.Su), YQ.Li, HY.Shen, Y.Motoo, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 4:358-362, Jul. 2006
Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells, (J.Pei-Hong), Y.Motoo, N.Sawabu, T.Minamoto, World journal of gastroenterology : WJG., 12:1597-1602, Mar. 2006
Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer, World J Gastroenterol, 12: 691-696, Feb. 2006
Tumor protein p53-induced nuclear protein 1 (TP53INP1) in spontaneous chronic pancreatitis in the WBN/Kob rat: drug effects on its expression in the pancreas., (P-H.Jiang), Y.Motoo, JL.Iovanna, M-J.Pebusque, M-J.Xie, G.Okada, N.Sawabu, Journal of the Pancreas, 5:205-216, 2004
Expression of vacuole membrane protein 1 (VMP1) in spontaneous chronic pancreatitis in the WBN/Kob rat., (P-H.Jiang), Y.Motoo, MI .Vaccaro, JL.Iovanna, G.Okada, N.Sawabu, Pancreas, 29:225-230, 2004
Expression of interleukin-8 in human obstructive pancreatitis., Y.Motoo, M-J.Xie, H.Mouri, N.Sawabu, Journal of the Pancreas (Online), 5:138-144, 2004
Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma., (M-J.Xie), Y.Motoo, JL.Iovanna, SB.Su, K.Ohtsubo, F.Matsubara, N.Sawabu, DIGESTIVE DISEASES AND SCIENCES, 48:459-64, 2003
Superoxide dismutase is induced during rat pancreatic acinar cell injury., (SB.Su), Y.Motoo, M-J.Xie, H.Mouri, K.Asayama, N.Sawabu, Pancreas, 24:146-152, 2002
Effect of carboxamide derivative IS-741 on rat spontaneous chronic pancreatitis., (M-J.Xie), Y.Motoo, SB.Su, JL.Iovanna, N.Sawabu, DIGESTIVE DISEASES AND SCIENCES, 47:139-147, 2002
Expression of p8 in human pancreatic cancer, (SB.Su), Y.Motoo, JL.Iovanna, M-J.Xie, H.Mouri, K.Ohtsubo, Y,Yamaguchi, H,Watanabe, T,Okai, F,Matsubara, N.Sawabu, Clin. Cancer Res., 7:309-313, Feb. 2001
p8 expression is induced in acinar cells during chronic pancreatitis., Y.Motoo, JL.Iovanna, GV.Mallo, SB.Su, M-J.Xie, N.Sawabu, DIGESTIVE DISEASES AND SCIENCES, 46:1640-1646, 2001
Usefulness of supernatant of pancreatic juice for genetic analysis of K-ras in diagnosis of pancreatic carcinoma., (A.Ha), H.Watanabe, Y.Yamaguchi, K.Ohtsubo, Y.Wang, Y.Motoo, T.Okai, T.Wakabayahi, N.Sawabu, PANCREAS, 23: 356?363, 2001
Pneumatosis intestinalis and hepatic portal venous gas caused by mesenteric ischemia in an aged person., (K.Ohtsubo), T.Okai, Y.Yamaguchi, H.Watanabe, Y.Motoo, O.Matsui, N.Sawabu, JOURNAL OF GASTROENTEROLOGY, 36:338-340, 2001
Pancreatitis-associated protein (PAP) levels in pancreatic juice from patients with pancreatic diseases., Y.Motoo, H.Watanabe, Y.Yamaguchi, M-J.Xie, N.Sawabu, PANCREATOLOGY, 1:43-47, 2001
Hepatic peribiliary cysts diagnosed by magnetic resonance cholangiography., Y.Motoo, Y.Yamaguchi, H.Watanabe, T.Okai, JOURNAL OF GASTROENTEROLOGY, 36:271-275, 2001
Expression of tumor necrosis factor-alpha, interleukin-6, and interferon-gamma in spontaneous chronic pancreatitis in the WBN/Kob rat., (M-J..Xie), Y.Motoo, SB.Su, N.Sawabu, PANCREAS, 22:400-408, 2001
Expression of clusterin in pancreatic acinar cell injuries in vivo and in vitro., Y.Motoo, M-J.Xie, SB.Su, N.Sawabu, PANCREAS, 22:126-134, 2001
Effect of herbal medicine Keishi-to (TJ-45) and its components on rat pancreatic acinar cell injuries in vivo and in vitro., Y.Motoo, SB.Su, M-J.Xie, H.Mouri, H.Taga, N.Sawabu, PANCREATOLOGY, 1:102-109, 2001
Apoptosis in rat spontaneous chronic pancreatitis:role of the Fas and Fas ligand system., (SB.Su), Y.Motoo, M-J.Xie, N.Sawabu, DIGESTIVE DISEASES AND SCIENCES, 46:166-175, 2001
Anti-fibrotic effect of herbal medicine Saiko-keishi-to (TJ-10) on chronic pancreatitis in the WBN/Kob rat., (SB.Su), Y.Motoo, M-J.Xie, H.Taga, N.Sawabu, PANCREAS, 22:8-17, 2001
Expression of transforming growth factor beta in spontaneous chronic pancreatitis in the WBN/Kob rat., (SB.Su), Y.Motoo, M-J.Xie, KMiyazono, N.Sawabu, DIGESTIVE DISEASES AND SCIENCES, 45:151-159, 2000
Effect of herbal medicine Saiko-keishi-to (TJ-10) on rat spontaneous chronic pancreatitis: comparison with other herbal medicines, Y.Motoo, SB.Su, M-JXie, H.Taga, N.Sawabu, INTERNATIONAL JOURNAL OF PANCREATOLOGY, 27:123-129, 2000
Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?, (T.Okai), K.Ohtsubo, J.Sakai, Y.Motoo, H.Watanabe, A.Kawashima, N.Sawabu, Canadian Journal of Gasroenterology, 14:761-766, 2000
Arginine induces apoptosis and gene expression of pancreatitis-associated protein (PAP) in pancreatic acinar AR4-2J cells., Y.Motoo, K.Taga, SB.Su, M-J.Xie, N.Sawabu, PANCREAS, 20:61-66, 2000
Urinary gonadotropin peptide as acute phase reactant: transient elevation after operation for digestive diseases., Y.Motoo, H.Watanabe, T.Okai, N.Sawabu, EUROPEAN JOURNAL OF ENDOCRINOLOGY, 140:555-560, 1999
Serum levels of pancreatitis-associated protein in digestive diseases with special reference to gastrointestinal cancers., Y.Motoo, Y.Satomura, I.Mouri, H.Mouri, K.Ohtsubo, J.Sakai, T.Fujii, H.Taga, Y.Yamaguchi, H.Watanabe, T,.Okai, N.Sawabu, Digestive Diseases and Sciences, 44:1142-1147, 1999
Pancreatic cancer associated with granulocyte-colony stimulating factor production confirmed by immunohistochemistry., (K.Ohtsubo), H.Mouri, M.Akasofu, Y.Yamaguchi, H.Watanabe, T.Gabata, Y.Motoo, T.Okai, N.Sawabu, J.Sakai, JOURNAL OF CLINICAL GASTROENTEROLOGY, 27:357-60, 1999
Mucin-producing biliary papillomatosis associated with gastrobiliary fistula., (K.Harada), Y.Nakanuma, H.Watanabe, Y.Motoo, T.Okai, N.Sawabu, JOURNAL OF GASTROENTEROLOGY, 34:141-4, 1999
K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma., (H.Watanabe), A.Ha, YX.Hu, K.Ohtsubo, Y.Yamaguchi, Y.Motoo, T.Okai, D.Toya, N.Tanaka, N.Sawabu, CANCER, 15:1441-1448, 1999
Expression of pancreatitis-associated protein (PAP) in rat spontaneous chronic pancreatitis: effect of herbal medicine Saiko-keishi-to (TJ-10)., (SB.Su), Y.Motoo, M-J.Xie, J.Sakai, H.Taga, N.Sawabu, PANCREAS, 19:239-247, 1999
Effect of Koso-san on globus pharyngeus., Y.Motoo, H.Taga, SB.Su, N.Sawabu, AMERICAN JOURNAL OF CHINESE MEDICINE, 27:283-288, 1999
EUS and K-ras analysis of pure pancreatic juice collected via a duodenoscope after secretion stimulation for diagnosis of pancreatic mass lesion: a prospective study., (T.Okai), H.Watanabe, Y.Yamaguchi, I.Mouri, Y.Motoo, N.Sawabu, GASTROINTESTINAL ENDOSCOPY, 50:797-803, 1999
Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma., (YX.Hu), H.Watanabe, K.Ohtsubo, Y.Yamaguchi, A.Ha, Y.Motoo, T.Okai, N.Sawabu, Br J Cancer, 80:1075-1079, 1999
Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay., (H.Watanabe), Y.Yamaguchi, A.Ha, YX.Hu, Y.Motoo, T.Okai, T.Yoshimura, N.Sawabu, PANCREAS, 17:341-347, 1998
Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma., (YX.Hu), H.Watanabe, K.Ohtsubo, Y.Yamaguchi, A.Ha, Y.Motoo, T.Okai, N.Sawabu, CLINICAL CANCER RESEARCH, 4:1147-1152, 1998
Expression of pancreatitis-associated protein (PAP) mRNA in gastrointestinal cancers, Y.Motoo, T.Itoh, SB.Su, MT.Nakatani, H.Watanabe, T.Okai, N.Sawabu, INTERNATIONAL JOURNAL OF PANCREATOLOGY, 23:11-16, 1998
Expression of multidrug resistance gene (mdr-1) mRNA in gastric and colorectal cancers., Y.Motoo, SB.Su, MT.Nakatani, N.Sawabu, ANTICANCER RESEARCH, 18:1903-1906, 1998
Chronic pancreatitis with diffuse irregular narrowing of the main pancreatic duct., (T.Wakabayashi), Y.Motoo, Y.Kojima, H.Makino, N.Sawabu, DIGESTIVE DISEASES AND SCIENCES, 43:2415-2425, 1998
Undifferentiated (anaplastic) carcinoma of the pancreas showing sarcomatous change and neoplastic cyst formation., Y.Motoo, A.Kawashima, H.Watanabe, SB.Su, T.Okai, Sawabu N, INTERNATIONAL JOURNAL OF PANCREATOLOGY, 21:243-248, 1997
Sclerosing pancreatitis showing rapidly progressive changes with recurrent mass formation., Y.Motoo, T.Minamoto, H.Watanabe, J.Sakai, T.Okai, N.Sawabu, INTERNATIONAL JOURNAL OF PANCREATOLOGY, 21:85-90, 1997
Prolonged intrahepatic cholestatsis in acute-onset, severe autoimmune hepatitis., Y.Motoo, N.Sawabu, H.Watanabe, T.Okai, Y.Nakanuma, JOURNAL OF GASTROENTEROLOGY, 32:410-413, 1997
Effect of niuche-shen-qi-wan on painful muscle cramps in patients with liver cirrhosis: a preliminary report., Y.Motoo, H.Taga, Y.Yamaguchi, H.Watanabe, T.Okai, N.Sawabu, AMERICAN JOURNAL OF CHINESE MEDICINE, 25:97-102, 1997
Effect of gegen-tang on painful gynecomastia in patients with liver cirrhosis: a brief report., Y.Motoo, H.Taga, SB.Su, N.Sawabu, AMERICAN JOURNAL OF CHINESE MEDICINE, 26:114, 1997
Biliary papillomatosis with the point mutation of K-ras gene arising in congenital choledochal cyst, (H,Ohta), Y.Yamaguchi, O.Yamakawa, H.Watanabe, Y.Satomura, Y.Motoo, T.Okai, T.Terada, N.Sawabu, Gastroenterology, 105:1209-1212, 1993
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma, (T.Takayama), M.Makuuchi, S.Hirohashi, M.Sakamoto, N.Okazaki, K.Takayasu, T.Kosuge, Y.Motoo, S.Yamazaki, H.Hasegawa, Lancet, 336:1150-1153, 1990
An exploratory study of social problems experienced by ambulatory cancer patients in Japan: Frequency and association with perceived need for help., Psychooncology, 27:1704-1710, Jul. 2018
Clinical practice guidelines for the management of olfactory dysfunction - Secondary publication, Miwa T, Ikeda K, Ishibashi T, Kobayashi M, Kondo K, Matsuwaki Y, Ogawa T, Shiga H, Suzuki M, Tsuzuki K, Furuta A, Motoo Y, Fujieda S, Kurono Y, Auris Nasus Larynx, 46:653-662, Oct. 2019
Perspectives on the use of ninjin'yoeito in modern medicine: a review of randomized controlled trials, (Takayama S), Arita R, Ohsawa M, Kikuchi A, Yasui H, Makino T, Motoo Y, Ishii T, Evidence-Based Complementary and Alternative Medicine, 2019:9590260, Sep. 2019
The utilization of complementary and alternative medicine in Taiwan: An internet survey using an adapted version of the international questionnaire (I-CAM-Q), ( Huang CW), Tran DNH, Li TF, Sasaki Y, Lee JA, Lee MS, Arai I, Motoo Y, Yukawa K, Tsutani K, Ko SG, Hwang SJ, Chen FP, Journal of the Chinese Medical Association, 82:656-671, Aug. 2019
Efficacy of daikenchuto, a traditional Japanese Kampo medicine, for postoperative intestinal dysfunction in patients with gastrointestinal cancers: meta-analysis, (Hosaka M), Arai I, Ishiura Y, Ito T, Seki Y, Naito T, Matsuzawa Y, Nakayama T, Motoo Y, International Journal of Clinical Oncology, 24:1385-1396, Jul. 2019
Complementary and Alternative Medicine for Breast Cancer Patients:An Overview of Systematic Reviews, Yui Sasaki, Chunhoo Cheon, Yoshiharu Motoo, Soobin Jang, Sunju Park, Seong-Gyu Ko, Bo-Hyoung Jang, Deok-Sang Hwang, YAKUGAKU ZASSHI, 139:1027-1046, Jul. 2019
Nivolumab-related sclerosing cholangitis in gastric cancer, Motoo Y, Internal Medicine, 58:1197, May. 2019
Internet survey on the provision of complementary and alternative medicine in Japanese private clinics: a cross-sectional study, Motoo Y, Yukawa K, Hisamura K, Tsutani K, Arai I, Journal of integrative medicine, 17:8-13, Jan. 2019
Use of complementary and alternative medicine in Japan: a cross-sectional internet survey using the Japanese version of the International Complementary and Alternative Medicine Questionnaire, Motoo Y, Yukawa K, Arai I, Hisamura K, Tsutani K, JMA Journal, 2:35-46, 2019
Estimated incidence per population of adverse drug reactions to Kampo medicines from the Japanese adverse drug event report database (JADER), (Arai I), Harada Y, Koda H, Tsutani K, Motoo Y, Traditional & Kampo Medicine, 7:3-16, Apr. 2020